Who Paid My Doc
A Phase 2b, Randomized, Observer-Blind, Antigen and Adjuvant Dose-Confirmation Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults =50 Years of Age
ClinicalTrials.gov NCT05501561
Research payments
$6,897,635
Through program year 2024, $6,897,635 in research payments was reported against A Phase 2b, Randomized, Observer-Blind, Antigen and Adjuvant Dose-Confirmation Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults =50 Years of Age, across 12,551 payments, paid by Seqirus USA Inc.
- Paid by
- Seqirus USA Inc
- ClinicalTrials.gov
- NCT05501561
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $352,191 | 4,683 |
| 2023 | Research | $1,648,375 | 4,158 |
| 2022 | Research | $4,897,069 | 3,710 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Brandon Essink Creighton, NE Named on 641 payments
- Harry Studdard Mobile, AL Named on 443 payments
- Earl Martin Tomball, TX Named on 426 payments
- Manuchehr Darani Santa Ana, CA Named on 416 payments
- Katherine Pearce Baton Rouge, LA Named on 394 payments
- Adam Brosz Grand Island, NE Named on 370 payments
- Farhan Siddiqui Spartanburg, SC Named on 324 payments
- Jason Haffizulla Tamarac, FL Named on 316 payments
- Ronald Surowitz Jupiter, FL Named on 290 payments
- Lisa Cohen Palm Harbor, FL Named on 271 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.